Use of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19

Overview

Journal J Clin Med Res

Specialty General Medicine

Date 2020 Jul 14

PMID 32655740

Citations 98

Authors

Abigail Sy Chan

Amit Rout

Affiliations

Soon will be listed here.

Abstract

Background: As the pandemic of coronavirus disease 2019 (COVID-19) continues, prognostic markers are now being identified. The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are easily accessible values that have been known to correlate with inflammation and prognosis in several conditions. We used the available data to identify the association of NLR and PLR with the severity of COVID-19.

Methods: A literature search using EMBASE, MEDLINE, and Google Scholar for studies reporting the use of NLR and PLR in COVID-19 published until April 28, 2020, was performed. Random effects meta-analysis was done to estimate standard mean difference (SMD) of NLR and PLR values with 95% confidence interval (CI) between severe and non-severe COVID-19 cases.

Results: A total of 20 studies with 3,508 patients were included. Nineteen studies reported NLR values, while five studies reported PLR values between severe and non-severe COVID-19 patients. Higher levels of NLR (SMD: 2.80, 95% CI: 2.12 - 3.48, P < 0.00001) and PLR (SMD: 1.82, 95% CI: 1.03 - 2.61, P < 0.00001)) were seen in patients with severe disease compared to non-severe disease.

Conclusions: NLR and PLR can be used as independent prognostic markers of disease severity in COVID-19.

Citing Articles

Comparison of Platelet Indices, Lymphocyte, and Systemic Inflammation Indices on Days 1 and 8 in Surviving and Non-Surviving COVID-19 Patients at Hasan Sadikin General Hospital, Bandung, Indonesia.

Harti G, Maulida S, Susandi E, Fadjari T, Sumardi U, Alisjahbana B J Blood Med. 2025; 16:61-74.

PMID: 39926111 PMC: 11806915. DOI: 10.2147/JBM.S499023.

Neutrophil-to-Lymphocyte and Platelet Ratio (N/LP Ratio), a Reliable Criterion for Predicting In-Hospital Mortality in Both Genders Infected With SARS-CoV-2.

Mohammadshahi J, Ghobadi H, Shargi A, Moradkhani H, Rezaei H, Kazemy M Mediators Inflamm. 2025; 2024:5720709.

PMID: 39759900 PMC: 11699982. DOI: 10.1155/mi/5720709.

Unveiling the hidden link: elevated platelets and T cell subsets in 5% of moderate COVID-19 patients 48 days post-onset.

An H, Li T, Yang L, Zhang X, Hu H, Zhang C Front Cell Infect Microbiol. 2024; 14:1498491.

PMID: 39628664 PMC: 11611820. DOI: 10.3389/fcimb.2024.1498491.

Evaluation of Inflammatory Markers in Patients with COVID-19 Combined with Type 2 Diabetes Mellitus.

Li J, Zhang Y, Wu R, Ma G, Sheng L, Feng Y Risk Manag Healthc Policy. 2024; 17:2535-2545.

PMID: 39479559 PMC: 11523978. DOI: 10.2147/RMHP.S490281.

The relationship between neutrophil/lymphocyte ratio, platelet/neutrophil ratio, and risk of urosepsis in patients who present with ureteral stones and suspected urinary tract infection.

Villanueva-Congote J, Hinojosa-Gonzalez D, Segall M, Eisner B World J Urol. 2024; 42(1):596.

PMID: 39466513 DOI: 10.1007/s00345-024-05229-1.

References

Angkananard T, Anothaisintawee T, McEvoy M, Attia J, Thakkinstian A . Neutrophil Lymphocyte Ratio and Cardiovascular Disease Risk: A Systematic Review and Meta-Analysis. Biomed Res Int. 2018; 2018:2703518. PMC: 6252240. DOI: 10.1155/2018/2703518. View

Ma J, Yin J, Qian Y, Wu Y . Clinical characteristics and prognosis in cancer patients with COVID-19: A single center's retrospective study. J Infect. 2020; 81(2):318-356. PMC: 7194544. DOI: 10.1016/j.jinf.2020.04.006. View

Lagunas-Rangel F . Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. J Med Virol. 2020; 92(10):1733-1734. PMC: 7228336. DOI: 10.1002/jmv.25819. View

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

Wei Y, Wang R, Zhang D, Tu Y, Chen C, Ji S . Risk factors for severe COVID-19: Evidence from 167 hospitalized patients in Anhui, China. J Infect. 2020; 81(1):e89-e92. PMC: 7162743. DOI: 10.1016/j.jinf.2020.04.010. View

Zhou X, Du Y, Huang Z, Xu J, Qiu T, Wang J . Prognostic value of PLR in various cancers: a meta-analysis. PLoS One. 2014; 9(6):e101119. PMC: 4072728. DOI: 10.1371/journal.pone.0101119. View

Hozo S, Djulbegovic B, Hozo I . Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005; 5:13. PMC: 1097734. DOI: 10.1186/1471-2288-5-13. View

Pedersen S, Ho Y . SARS-CoV-2: a storm is raging. J Clin Invest. 2020; 130(5):2202-2205. PMC: 7190904. DOI: 10.1172/JCI137647. View

Sun S, Cai X, Wang H, He G, Lin Y, Lu B . Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clin Chim Acta. 2020; 507:174-180. PMC: 7194694. DOI: 10.1016/j.cca.2020.04.024. View

10.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View

11.

Wang Y, Ju M, Chen C, Yang D, Hou D, Tang X . Neutrophil-to-lymphocyte ratio as a prognostic marker in acute respiratory distress syndrome patients: a retrospective study. J Thorac Dis. 2018; 10(1):273-282. PMC: 5863192. DOI: 10.21037/jtd.2017.12.131. View

12.

Qu R, Ling Y, Zhang Y, Wei L, Chen X, Li X . Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol. 2020; 92(9):1533-1541. PMC: 7228291. DOI: 10.1002/jmv.25767. View

13.

Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S . Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020; 180(7):934-943. PMC: 7070509. DOI: 10.1001/jamainternmed.2020.0994. View

14.

Zhu Z, Cai T, Fan L, Lou K, Hua X, Huang Z . Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019. Int J Infect Dis. 2020; 95:332-339. PMC: 7195003. DOI: 10.1016/j.ijid.2020.04.041. View

15.

Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

16.

Templeton A, McNamara M, Seruga B, Vera-Badillo F, Aneja P, Ocana A . Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014; 106(6):dju124. DOI: 10.1093/jnci/dju124. View

17.

Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F . Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission. Clin Infect Dis. 2020; 71(15):896-897. PMC: 7184372. DOI: 10.1093/cid/ciaa415. View

18.

Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H . Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020; 130(5):2620-2629. PMC: 7190990. DOI: 10.1172/JCI137244. View

19.

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

20.

Garg S, Kim L, Whitaker M, OHalloran A, Cummings C, Holstein R . Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(15):458-464. PMC: 7755063. DOI: 10.15585/mmwr.mm6915e3. View